Rehmann Capital Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $760K | Buy |
|
|||||
|
2025
Q1 | $758K | Buy |
|
|||||
|
2024
Q4 | $610K | Sell |
|
|||||
|
2024
Q3 | $906K | Sell |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $1.02M | Buy |
|
|||||
|
2023
Q3 | $768K | Hold |
|
|||||
|
2023
Q2 | $777K | Sell |
|
|||||
|
2023
Q1 | $809K | Sell |
|
|||||
|
2022
Q4 | $750K | Buy |
|
|||||
|
2022
Q3 | $732K | Buy |
|
|||||
|
2022
Q2 | $650K | Sell |
|
|||||
|
2022
Q1 | $745K | Buy |
|
|||||
|
2021
Q4 | $529K | Sell |
|
|||||
|
2021
Q3 | $466K | Sell |
|
|||||
|
2021
Q2 | $502K | Buy |
|
|||||
|
2021
Q1 | $451K | Buy |
|
|||||
|
2020
Q4 | $431K | Sell |
|
|||||
|
2020
Q3 | $552K | Buy |
|
|||||
|
2020
Q2 | $557K | Buy |
|
|||||
|
2020
Q1 | $362K | Buy |
|
|||||
|
2019
Q3 | $330K | Buy |
|
|||||
|
2019
Q2 | $80.7K | Sell |
|
|||||
|
2019
Q1 | $81.1K | Buy |
|
|||||
|
2018
Q4 | $67.8K | Buy |
|
|||||
|
2018
Q3 | $64.4K | Sell |
|
|||||
|
2018
Q2 | $63.9K | Sell |
|
|||||
|
2018
Q1 | $228K | Buy |
|